Saturday, August 22, 2015

The cat's on the prowl

Almost an year since then, while nothing earth shattering some serious stuff is surely happening at Calico.

Towards making its journey to tackling ageing a smooth affair, Calico has started to identify some fun-n-fit travel-mates, hoard the essentials, chart-out the best road to take & mark-out the detours to make.

Partnered with The Buck Institute, which is the foremost Geroscienceinstitution & works on aspects as diverse as understanding & altering neurodegenerative processes; Dietary Restriction as a way to modulate ageing to pinpointing Stochastic aspects of cellular degeneration.

Partnered with Q3B, which is pursuing the biomedical promise by way of seeding dozens of start-ups in its incubators

Collaborating with Broad Institute that’s crisping up the human genome by resolving the operational portion of it & importantly is developing a new way to discover & re-purpose drugs

The above partnerships are a mix of investment into longer-term scientific breakthroughs and shorter-term stake in innovative biomedical start-ups challenging the routine (Q3B) and showcase Calico’s adherence to its core purpose. But looking at the high focus on neurodegenerative research at Buck Institute (6 out of 9 research components) and UCSF, it's likely the first milestone Calico wishes to reach is tackling cognitive decline linked to ageing.